AngioDynamics Port Catheter Lawsuits: What Patients Demand to Know About Defective Implantable Ports

Implantable port catheters are critical tools for patients requiring long-term intravenous access for chemotherapy, fluids, and other essential medications. However, a growing number of lawsuits allege that certain port catheters manufactured by AngioDynamics and its subsidiary, Navilyst Medical, contain a dangerous design defect that puts patients at risk of life-threatening complications.

These legal actions claim that the devices can degrade and fail inside the body, leading to severe injuries that often require emergency surgical intervention. In October 2024, these cases were consolidated into multidistrict litigation (MDL 3125) in the Southern District of California to streamline the legal process for affected individuals.

The “Barium Sulfate” Design Defect

At the center of the litigation is a specific manufacturing issue involving barium sulfate. This compound is added to the polyurethane plastic tubing of the catheter to develop the device visible on X-rays and CT scans, allowing physicians to verify correct placement.

Plaintiffs allege that excessive concentrations of barium sulfate compromise the structural integrity of the catheter. When too much of this compound is mixed into the plastic, it creates air pockets and structural flaws. This results in:

• Microfractures: Small cracks and pitting on the surface of the catheter.
• Material Degradation: The plastic becomes brittle, making the device prone to breaking apart entirely.
• Structural Failure: The catheter may fracture or migrate from its original position within the body.

Serious Health Complications Linked to Defective Ports

When a port catheter fails or degrades, the consequences can be catastrophic. The rough surfaces and structural breaks created by the barium sulfate defect lead to several critical medical issues:

Sepsis and Severe Infections

The microfractures and pitting on the catheter’s surface provide ideal hiding places for bacteria to colonize. Once bacteria enter the bloodstream through these degraded areas, patients can develop severe infections or sepsis, a life-threatening systemic response to infection.

Blood Clots and Thrombosis

A smooth internal surface is vital for preventing clots. The degraded, rough surface of a defective AngioDynamics catheter promotes the formation of blood clots (thrombosis). These clots can travel through the bloodstream, potentially causing a pulmonary embolism or a stroke.

Catheter Fracture and Migration

In some cases, the catheter material breaks apart entirely. Fragments of the device can migrate through the vascular system and travel to vital organs, including the heart, and lungs. These migrating pieces can cause organ or vessel perforation, piercing internal tissues and vascular walls.

Affected Models and Legal Status

The litigation specifically identifies several models that may contain these defects, including the Vortex, SmartPort, and Xcela ports. Lawsuits allege that AngioDynamics was aware of these design flaws but failed to warn consumers and healthcare providers about the potential harms.

Currently, more than 300 lawsuits have been consolidated into MDL 3125 (IN RE: AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation). Plaintiffs are seeking compensation for medical bills, pain and suffering, and the costs associated with emergency revision surgeries to remove or replace the damaged devices.

Frequently Asked Questions

What should I do if I have an AngioDynamics port?

Individuals who have received an AngioDynamics port catheter should consult their healthcare provider to monitor the device’s integrity. If you experience signs of infection, unusual pain, or shortness of breath, seek medical attention immediately.

What are the symptoms of a failing port catheter?

While symptoms vary, warning signs can include fever or chills (indicating infection), swelling or pain at the port site, or sudden respiratory distress (which could indicate a pulmonary embolism caused by a blood clot).

Can I still join the lawsuit?

According to legal reviews, individuals harmed by these devices may still be eligible to join the group litigation. Consulting with a qualified attorney can help determine eligibility based on the specific device model and injuries sustained.

Looking Ahead

As the MDL 3125 litigation progresses, more evidence regarding the manufacturing process and internal company knowledge may reach to light. For patients, the priority remains vigilant medical monitoring and ensuring that any complications are documented and addressed by medical professionals to prevent long-term organ damage or life-threatening events.